SY
Spyre Ther
SYRE·NASDAQWaltham MAFounded 202350 employees
Small CapbiotechPublicImmunologyGI
Platform: IL-13 Ab GI
Market Cap
$1.2B
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (SYRE)
Loading SYRE stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kematenlimab | SYR-2713 | Phase 2/3 | 1 | CD3 | MDSIgAN | ||
| SYR-7044 | SYR-7044 | Phase 3 | 2 | PARP | NASHPsA |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)